The 2nd Gene Therapy Immunogenicity Summit is the industry’s definitive forum enabling you to better modulate, measure and predict immune response to your gene therapy c
SMi Reports: This year’s Immuno-Oncology conference, taking place 26th - 27th September in London, aims to address the issues and challenges burdening the industry, as well as the promising advance
Software that can be used to monitor patients with neurodegenerative disorder amyotrophic lateral sclerosis (ALS) using their voice patterns has been granted breakthrough
